Subsequently, antigenic peptides are loaded into the peptide-binding groove to form a stable pMHC-I complex, which disengages from the PLC and is transported to the surface of tumor cells through Golgi for recognition by the T cell receptor (TCR) on CTLs to eradicate tumor cells. Here, HSPG2 is linked to neoplasm.